Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy
Rentsch, C., Bosshard, P., Mayor, G., Rieken, M., Püschel, H., Wirth, G., Cathomas, R., Grode, L., Parzmair, G., Eisele, B., Sharma, H., Shaligram, U., Goldenberger, D., Spertini, F., Audran, R., Enoui, M., Berardi-Vilei, S., Hayoz, S., Wicki, A.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Get full text
Journal Article
728 - Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy
Rentsch, C., Bosshard, P., Mayor, G., Rieken, M., Püschel, H., Wirth, G., Cathomas, R., Grode, L., Parzmair, G., Eisele, B., Sharma, H., Shaligram, U., Goldenberger, D., Spertini, F., Audran, R., Enoui, M., Berardi-Vilei, S., Hayoz, S., Wicki, A.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Get full text
Journal Article